Status:
TERMINATED
Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri
Lead Sponsor:
University Hospital, Strasbourg, France
Collaborating Sponsors:
Biogen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
To evaluate the diagnosis value of MRI and positon emission tomography (PET) scan for studying macrophagic infiltration and other brain modification in multiple sclerosis (MS) patients treated with Na...
Eligibility Criteria
Inclusion
- Patients diagnosed with MS
- Treatment with Tysabri planned
Exclusion
- Allergy to Tysabri or MRI contrast products
- Pregnancy
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00752778
Start Date
December 1 2008
End Date
March 1 2011
Last Update
November 12 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Neurologie, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 37091
2
Service de Médecine Nucléaire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67098
3
Service de Radiologie 2, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67098